- Statement 1 is incorrect: Covishield, manufactured by the Serum Institute of India, is the Oxford- AstraZeneca vaccine. It uses a viral vector platform (specifically, a modified chimpanzee adenovirus) to deliver the genetic material for the SARS-CoV-2 spike protein. It is not an mRNA vaccine. - Statement 2 is correct: Sputnik V, developed by the Gamaleya Research Institute in Russia, is an adenoviral vector vaccine. It uses two different human adenoviruses (Ad26 and Ad5) for the two doses. - Statement 3 is correct: COVAXIN, developed by Bharat Biotech in India, is an inactivated pathogen- based vaccine. It uses the whole SARS-CoV-2 virus, which has been chemically inactivated so it cannot replicate or cause disease, but can still trigger an immune response.